We partner with employers, health plans, and benefits brokers to bring preventive screenings directly to employees at home. The ReperioKit™ delivers instant results through Bluetooth-connected medical devices, followed immediately by a virtual visit with a credentialed clinician — covered as a preventive benefit.

→ Thousands of screenings completed with a 96% completion rate
→ Contracted with major commercial health plans
→ $0 cost to employees, covered under ACA
→ SOC-2 compliant · Licensed in all 50 states + DC

We’re building toward a future where engaging with the healthcare system is as simple and immediate as the rest of the digital services we rely on every day. Reperio delivers real-time insight into your health and an instant connection to a credentialed provider who can interpret results, assess risk, and guide next steps. What has historically been a fragmented, weeks-long journey—from screening to results to provider follow-up—becomes a single, seamless encounter, all from home. The result is earlier action for patients and better outcomes for the organizations that support them.

→ AI agent "Toby" for continuous patient engagement at scale
→ "Apex" AI co-pilot revolutionizing preventive provider visits
→ Longitudinal records shared via Kno2 / TEFCA national exchange
→ Uber-like clinical network enabling truly on-demand care nationwide
→ Competitive moat around IP and exclusive agreements

ReperioKit™ ships anywhere in the U.S. and arrives in a simple, convenient mailer box.

Bluetooth medical devices pair with our app to capture a full preventive panel instantly, no lab needed.

✓ Blood pressure
✓ Heart rate
✓ Body Mass Index
✓ Relative Fat Mass
✓ Glucose
✓ Total Cholesterol
✓ HDL Cholesterol
✓ LDL Cholesterol
✓ Triglycerides

Patented Bluetooth-integrated system · U.S. Patent No. 11,488,707

✓ EHR data ingested via Kno2 (TEFCA QHIN)
✓ "Apex" AI co-pilot evaluates full medical history
✓ Automatic live transcription of provider visit
✓ AI-generated SOAP notes & After Visit Summary
✓ Uber-like provider network for on-demand clinician availability
✓ Billable as a preventive claim

condition discovery rate

opt-in rate

Customer Satisfaction

Increased Participation vs. Onsite

preference for at-home experience

near perfect renewal rate

A 10-year exclusive partnership with PTS Diagnostics — owners of the FDA-cleared instant blood testing device used by 90% of the global onsite screening market. Reperio is the only company permitted to ship their CLIA-waived device in an at-home kit, through 2032.

Reperio owns the patent for its Bluetooth-integrated modular health testing system — the communications hub connecting multiple physical health testing devices to a smartphone app for real-time results display.

Six purpose-built platforms in-house: patient app with AI agent "Toby", provider app, "Apex" AI co-pilot telehealth platform, ReperioKit™ patented firmware, internal ops platform "Pulse", and CRM "Novo". 

(See below for details)

A licensed medical practice in all 50 states and Washington DC, with a proprietary Uber-like provider credentialing network. Pursuing Delegated Agent status — cutting provider onboarding from 90–120 days to just 30.

Integrated with Kno2, a TEFCA QHIN, enabling bi-directional sharing of screening and visit EHR data across the national health information exchange — a capability almost no telehealth company has built.

Fully SOC-2 compliant as both a health tech service and provider practice. Contracted in-network with Aetna nationally, Highmark BCBS, Anthem BCBS New Hampshire, First Health across 45+ states — with Blues and other plan contracting advancing.